Short answer
FORMFACTOR INC (FORM) filed an 8-K current report with the SEC on October 13, 2026 reporting Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Private placement to Teradyne: 2,234,887 FormFactor shares for approximately $300.0 million cash.
FORMFACTOR INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 3.02 · Unregistered Sales of Equity Securities
- Private placement to Teradyne: 2,234,887 FormFactor shares for approximately $300.0 million cash
- Expected fourth-quarter fiscal 2026 closing, subject to customary conditions
- Approximately $300.0 million capital infusion, strengthening liquidity without public-market issuance
- Teradyne receives a strategic equity position, creating potential commercial or governance significance for shareholders
Item 7.01 · Regulation FD Disclosure
- Press release announces a private placement, indicating new financing and potential shareholder dilution
- Exhibit 99.1 contains transaction details investors need to assess proceeds, pricing and use of funds
Item EX-99.1 · Exhibit EX-99.1
- Strategic technology collaboration with Teradyne spanning probe, interface, and automated test technologies
- Focus on AI, HPC, advanced packaging, HBM, and silicon photonics semiconductor applications
- Teradyne agreed to invest $300 million in FormFactor equity, subject to regulatory approvals and customary closing conditions
- Potential strategic upside from joint customer engagement and faster transition from development to high-volume production
- Investment timing and collaboration benefits remain uncertain, with forward-looking statements subject to execution and regulatory risks
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other FORMFACTOR INC 8-K filings
Get the next FORM 8-K as it lands
Follow FORM for push alerts, or ask the research agent what this filing means.